These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3142093

  • 1. Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60.
    Alving BM, Krishnamurti C, Liu YP, Lucas DL, Wright DG.
    Thromb Res; 1988 Jul 15; 51(2):175-85. PubMed ID: 3142093
    [Abstract] [Full Text] [Related]

  • 2. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
    Genton C, Kruithof EK, Schleuning WD.
    J Cell Biol; 1987 Mar 15; 104(3):705-12. PubMed ID: 3102504
    [Abstract] [Full Text] [Related]

  • 3. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA, Medcalf RL, Kruithof EK.
    Endocrinology; 1993 Oct 15; 133(4):1724-30. PubMed ID: 8404615
    [Abstract] [Full Text] [Related]

  • 4. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR, Webb AC, Sitrin RG.
    J Immunol; 1988 Oct 15; 141(8):2693-8. PubMed ID: 3139763
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R.
    J Cell Physiol; 1989 Jul 15; 140(1):119-30. PubMed ID: 2500450
    [Abstract] [Full Text] [Related]

  • 6. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ, Sitrin RG.
    J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845
    [Abstract] [Full Text] [Related]

  • 7. Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562).
    Oliver LJ, Keeton M, Wilson EL.
    Blood; 1989 Sep 01; 74(4):1321-7. PubMed ID: 2504306
    [Abstract] [Full Text] [Related]

  • 8. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
    Rondeau E, Guidet B, Lacave R, Bens M, Sraer J, Nagamine Y, Ardaillou R, Sraer JD.
    Biochim Biophys Acta; 1990 Nov 12; 1055(2):165-72. PubMed ID: 2122915
    [Abstract] [Full Text] [Related]

  • 9. Calcitriol-mediated modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2.
    Kole KL, Gyetko MR, Simpson RU, Sitrin RG.
    Biochem Pharmacol; 1991 Feb 15; 41(4):585-91. PubMed ID: 1900005
    [Abstract] [Full Text] [Related]

  • 10. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes.
    Krishnamurti C, Alving B.
    Rev Infect Dis; 1989 Feb 15; 11 Suppl 4():S843-6. PubMed ID: 2501855
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus.
    Krishnamurti C, Wahl LM, Alving BM.
    Am J Trop Med Hyg; 1989 Jan 15; 40(1):102-7. PubMed ID: 2492775
    [Abstract] [Full Text] [Related]

  • 12. Human HuH-7 hepatoma cells express urokinase and plasminogen activator inhibitor-1: identification, characterization and regulation by inflammatory mediators.
    Arndt A, Murphy P, Hart DA.
    Biochim Biophys Acta; 1992 Feb 14; 1138(2):149-56. PubMed ID: 1371701
    [Abstract] [Full Text] [Related]

  • 13. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
    Benjamin LA, McGarry RC, Hart DA.
    Cancer Chemother Pharmacol; 1989 Feb 14; 25(1):25-31. PubMed ID: 2590998
    [Abstract] [Full Text] [Related]

  • 14. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
    Tienari J, Alanko T, Lehtonen E, Saksela O.
    Cell Regul; 1991 Apr 14; 2(4):285-97. PubMed ID: 1905574
    [Abstract] [Full Text] [Related]

  • 15. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D, Strandberg L, Grundström T, Ny T.
    Eur J Biochem; 1989 Dec 22; 186(3):523-33. PubMed ID: 2514093
    [Abstract] [Full Text] [Related]

  • 16. Treatment of mouse L-cells with phorbol myristate acetate induces the secretion of a plasminogen activator inhibitor which binds to human and mouse urokinase and human tissue plasminogen activator.
    Rehemtulla A, Gates J, Hart DA.
    Comp Biochem Physiol B; 1987 Dec 22; 88(1):277-83. PubMed ID: 3119281
    [Abstract] [Full Text] [Related]

  • 17. Urokinase synthesis and binding by glomerular epithelial cells in culture.
    Rondeau E, Ochi S, Lacave R, He CJ, Medcalf R, Delarue F, Sraer JD.
    Kidney Int; 1989 Oct 22; 36(4):593-600. PubMed ID: 2554052
    [Abstract] [Full Text] [Related]

  • 18. Production of protease inhibitors by postsurgical macrophages.
    Fukasawa M, Campeau JD, Girgis W, Bryant SM, Rodgers KE, DiZerega GS.
    J Surg Res; 1989 Mar 22; 46(3):256-61. PubMed ID: 2493532
    [Abstract] [Full Text] [Related]

  • 19. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
    Niiya K, Sakuragawa N.
    Nihon Rinsho; 1992 Feb 22; 50(2):325-9. PubMed ID: 1319513
    [Abstract] [Full Text] [Related]

  • 20. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
    Takeuchi T, Niiya K, Kubonishi I, Miyoshi I.
    Thromb Haemost; 1990 Apr 12; 63(2):259-64. PubMed ID: 2363126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.